reported that SNPs in the serotonin 2a receptor (5-HTR2a) and variations in the number of tandem repeats in the intron region of the serotonin transporter gene exhibited no effect on depression risk among breast cancer patients. This evidence concerns the gene HTR2A and major depressive disorder.